Trial Profile
Randomized double-blinding controlled multicenter trial of Novaferon for Chronic hepatitis B.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 May 2012
Price :
$35
*
At a glance
- Drugs Novaferon (Primary) ; Interferon alpha-2b
- Indications Hepatitis B
- Focus Registrational; Therapeutic Use
- 21 May 2012 Planned End Date changed from 1 Jan 2011 to 31 Mar 2011 as reported by Chinese Clinical Trial Register record.
- 01 Oct 2010 New trial record